Global and United States Computational Immunology Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Computational Immunology Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Cancer Diagnosis & Therapy
  • 1.2.3 Reverse Vaccinology
  • 1.2.4 Immune System Modeling
• 1.3 Market by Application
  • 1.3.1 Global Computational Immunology Market Share by Application: 2020 VS 2026
  • 1.3.2 Allergy Prediction Databases
  • 1.3.3 Analysis Resource Database
  • 1.3.4 International Immunogenetics System
  • 1.3.5 The Ontology Of Immune Epitopes
  • 1.3.6 Immune Epitope Database
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Computational Immunology Market Perspective (2015-2026)
• 2.2 Global Computational Immunology Growth Trends by Regions
  • 2.2.1 Computational Immunology Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Computational Immunology Historic Market Share by Regions (2015-2020)
  • 2.2.3 Computational Immunology Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Computational Immunology Players by Market Size
  • 3.1.1 Global Top Computational Immunology Players by Revenue (2015-2020)
  • 3.1.2 Global Computational Immunology Revenue Market Share by Players (2015-2020)
• 3.2 Global Computational Immunology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Computational Immunology Revenue
• 3.4 Global Computational Immunology Market Concentration Ratio
  • 3.4.1 Global Computational Immunology Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Computational Immunology Revenue in 2019
• 3.5 Key Players Computational Immunology Area Served
• 3.6 Key Players Computational Immunology Product Solution and Service
• 3.7 Date of Enter into Computational Immunology Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Computational Immunology Breakdown Data by Type (2015-2026)

• 4.1 Global Computational Immunology Historic Market Size by Type (2015-2020)
• 4.2 Global Computational Immunology Forecasted Market Size by Type (2021-2026)

5 Computational Immunology Breakdown Data by Application (2015-2026)

• 5.1 Global Computational Immunology Historic Market Size by Application (2015-2020)
• 5.2 Global Computational Immunology Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Computational Immunology Market Size (2015-2026)
• 6.2 North America Computational Immunology Market Size by Type (2015-2020)
• 6.3 North America Computational Immunology Market Size by Application (2015-2020)
• 6.4 North America Computational Immunology Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Computational Immunology Market Size (2015-2026)
• 7.2 Europe Computational Immunology Market Size by Type (2015-2020)
• 7.3 Europe Computational Immunology Market Size by Application (2015-2020)
• 7.4 Europe Computational Immunology Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Computational Immunology Market Size (2015-2026)
• 8.2 China Computational Immunology Market Size by Type (2015-2020)
• 8.3 China Computational Immunology Market Size by Application (2015-2020)
• 8.4 China Computational Immunology Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Computational Immunology Market Size (2015-2026)
• 9.2 Japan Computational Immunology Market Size by Type (2015-2020)
• 9.3 Japan Computational Immunology Market Size by Application (2015-2020)
• 9.4 Japan Computational Immunology Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Computational Immunology Market Size (2015-2026)
• 10.2 Southeast Asia Computational Immunology Market Size by Type (2015-2020)
• 10.3 Southeast Asia Computational Immunology Market Size by Application (2015-2020)
• 10.4 Southeast Asia Computational Immunology Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 EpiVax
  • 11.1.1 EpiVax Company Details
  • 11.1.2 EpiVax Business Overview
  • 11.1.3 EpiVax Computational Immunology Introduction
  • 11.1.4 EpiVax Revenue in Computational Immunology Business (2015-2020))
  • 11.1.5 EpiVax Recent Development
• 11.2 Novozymes Biopharma
  • 11.2.1 Novozymes Biopharma Company Details
  • 11.2.2 Novozymes Biopharma Business Overview
  • 11.2.3 Novozymes Biopharma Computational Immunology Introduction
  • 11.2.4 Novozymes Biopharma Revenue in Computational Immunology Business (2015-2020)
  • 11.2.5 Novozymes Biopharma Recent Development
• 11.3 ioGenetics
  • 11.3.1 ioGenetics Company Details
  • 11.3.2 ioGenetics Business Overview
  • 11.3.3 ioGenetics Computational Immunology Introduction
  • 11.3.4 ioGenetics Revenue in Computational Immunology Business (2015-2020)
  • 11.3.5 ioGenetics Recent Development
• 11.4 International Society of Vaccines
  • 11.4.1 International Society of Vaccines Company Details
  • 11.4.2 International Society of Vaccines Business Overview
  • 11.4.3 International Society of Vaccines Computational Immunology Introduction
  • 11.4.4 International Society of Vaccines Revenue in Computational Immunology Business (2015-2020)
  • 11.4.5 International Society of Vaccines Recent Development
• 11.5 IMGT
  • 11.5.1 IMGT Company Details
  • 11.5.2 IMGT Business Overview
  • 11.5.3 IMGT Computational Immunology Introduction
  • 11.5.4 IMGT Revenue in Computational Immunology Business (2015-2020)
  • 11.5.5 IMGT Recent Development
• 11.6 Dassault Systemes
  • 11.6.1 Dassault Systemes Company Details
  • 11.6.2 Dassault Systemes Business Overview
  • 11.6.3 Dassault Systemes Computational Immunology Introduction
  • 11.6.4 Dassault Systemes Revenue in Computational Immunology Business (2015-2020)
  • 11.6.5 Dassault Systemes Recent Development
• 11.7 Certara
  • 11.7.1 Certara Company Details
  • 11.7.2 Certara Business Overview
  • 11.7.3 Certara Computational Immunology Introduction
  • 11.7.4 Certara Revenue in Computational Immunology Business (2015-2020)
  • 11.7.5 Certara Recent Development
• 11.8 Chemical Computing Group
  • 11.8.1 Chemical Computing Group Company Details
  • 11.8.2 Chemical Computing Group Business Overview
  • 11.8.3 Chemical Computing Group Computational Immunology Introduction
  • 11.8.4 Chemical Computing Group Revenue in Computational Immunology Business (2015-2020)
  • 11.8.5 Chemical Computing Group Recent Development
• 11.9 Compugen
  • 11.9.1 Compugen Company Details
  • 11.9.2 Compugen Business Overview
  • 11.9.3 Compugen Computational Immunology Introduction
  • 11.9.4 Compugen Revenue in Computational Immunology Business (2015-2020)
  • 11.9.5 Compugen Recent Development
• 11.10 Genedata AG
  • 11.10.1 Genedata AG Company Details
  • 11.10.2 Genedata AG Business Overview
  • 11.10.3 Genedata AG Computational Immunology Introduction
  • 11.10.4 Genedata AG Revenue in Computational Immunology Business (2015-2020)
  • 11.10.5 Genedata AG Recent Development
• 11.11 Insilico Biotechnology AG
  • 10.11.1 Insilico Biotechnology AG Company Details
  • 10.11.2 Insilico Biotechnology AG Business Overview
  • 10.11.3 Insilico Biotechnology AG Computational Immunology Introduction
  • 10.11.4 Insilico Biotechnology AG Revenue in Computational Immunology Business (2015-2020)
  • 10.11.5 Insilico Biotechnology AG Recent Development
• 11.12 Leadscope Inc
  • 10.12.1 Leadscope Inc Company Details
  • 10.12.2 Leadscope Inc Business Overview
  • 10.12.3 Leadscope Inc Computational Immunology Introduction
  • 10.12.4 Leadscope Inc Revenue in Computational Immunology Business (2015-2020)
  • 10.12.5 Leadscope Inc Recent Development
• 11.13 Nimbus Discovery
  • 10.13.1 Nimbus Discovery Company Details
  • 10.13.2 Nimbus Discovery Business Overview
  • 10.13.3 Nimbus Discovery Computational Immunology Introduction
  • 10.13.4 Nimbus Discovery Revenue in Computational Immunology Business (2015-2020)
  • 10.13.5 Nimbus Discovery Recent Development
• 11.14 Strand Life Sciences
  • 10.14.1 Strand Life Sciences Company Details
  • 10.14.2 Strand Life Sciences Business Overview
  • 10.14.3 Strand Life Sciences Computational Immunology Introduction
  • 10.14.4 Strand Life Sciences Revenue in Computational Immunology Business (2015-2020)
  • 10.14.5 Strand Life Sciences Recent Development
• 11.15 Schrodinger
  • 10.15.1 Schrodinger Company Details
  • 10.15.2 Schrodinger Business Overview
  • 10.15.3 Schrodinger Computational Immunology Introduction
  • 10.15.4 Schrodinger Revenue in Computational Immunology Business (2015-2020)
  • 10.15.5 Schrodinger Recent Development
• 11.16 Simulation Plus
  • 10.16.1 Simulation Plus Company Details
  • 10.16.2 Simulation Plus Business Overview
  • 10.16.3 Simulation Plus Computational Immunology Introduction
  • 10.16.4 Simulation Plus Revenue in Computational Immunology Business (2015-2020)
  • 10.16.5 Simulation Plus Recent Development
• 11.17 Rosa & Co
  • 10.17.1 Rosa & Co Company Details
  • 10.17.2 Rosa & Co Business Overview
  • 10.17.3 Rosa & Co Computational Immunology Introduction
  • 10.17.4 Rosa & Co Revenue in Computational Immunology Business (2015-2020)
  • 10.17.5 Rosa & Co Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer